Protego Stock
Protego is a biotechnology company focused on discovering and developing novel small‑molecule therapeutics that aim to correct protein misfolding, a root cause of many serious diseases. It uses advanced scientific methods and pharmacological approaches to stabilize or reprogram how proteins fold in the body, with the goal of creating disease‑modifying treatments rather than just managing symptoms. The company’s work targets complex conditions driven by protein misfolding and seeks to bring innovative therapies forward through rigorous research and clinical development.
Sign up for SecondMarket® to view the market and buy or sell Protego Stock
Buy + SellProtego Funding
Sign up to gain insights into Protego funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series B | Dec 01, 2025 | 15.00M | ||
| Series B | Dec 01, 2025 | 82.06M | ||
| Series B | Oct 17, 2025 | 32.94M | ||
| Series A | Oct 19, 2021 | 1.26M | ||
| Series A | Oct 19, 2021 | 33.07M | ||
| Seed | Dec 06, 2019 | 796.14K |
See Protego Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Protego Stock Valuation + Share Prices
View real-time Tape D® data on Protego stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Protego Management Team
-
Board Member
Ed Hurwitz
-
Board Member
Laura Brass
-
Board Member
Helen Kim
-
Board Member
Tim Lohoff
-
Board Member
Saoussen Ben Halima
-
Board Member
Jeffrey Kelly
-
Board Member
Janwillem Naesens
-
Board Member
Shelley Chu
-
CEO, Board Member
Brent Warner
-
Chief Scientific Officer
Mike Petrassi
Protego Major Investors
-
Forbion Capital Partners
-
Omega Funds
-
Lightspeed Venture Partners
-
Digitalis Ventures
-
MPM BioImpact
-
YK Bioventures
-
Scripps Research
-
Droia Ventures
-
MPM Capital
-
Vida Ventures
-
Novartis
Learn More About Protego Stock
Buy Protego Stock
01Protego stock does not trade on public stock exchanges. Protego stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Protego stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Protego Stock
02Protego Stock does not trade on public stock exchanges. In order to sell Protego shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Protego Stock Price
03Protego does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Protego share price and other valuable private market data.
Read more about secondary market private company stock prices:
Protego Stock Ticker Symbol
04There is no ticker symbol for Protego stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Protego Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Protego stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Protego Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Protego stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Protego Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Protego IPO
08Protego is a private company and has not had an IPO. There is currently no Protego IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Protego IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Protego Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
